HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M500021-MCP200v1 4/6/785    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benzinger, A. Articles by Hermeking, H. Search for Related Content PubMed PubMed Citation Articles by Benzinger, A. Articles by Hermeking, H. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 4:785-795, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Targeted Proteomic Analysis of 14-3-3, a p53 Effector Commonly Silenced in Cancer^*,S

Anne Benzinger, Nemone Muster^,¶, Heike B. Koch, John R. Yates, III^,¶ and Heiko Hermeking^,||

From the Molecular Oncology, Max-Planck-Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried/Munich, Germany and Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037

To comprehensively identify proteins interacting with 14-3-3 in vivo, tandem affinity purification and the multidimensional protein identification technology were combined to characterize 117 proteins associated with 14-3-3 in human cells. The majority of identified proteins contained one or several phosphorylatable 14-3-3-binding sites indicating a potential direct interaction with 14-3-3. 25 proteins were not previously assigned to any function and were named SIP2–26 (for 14-3-3-interacting protein). Among the 92 interactors with known function were a number of proteins previously implicated in oncogenic signaling (APC, A-RAF, B-RAF, and c-RAF) and cell cycle regulation (AJUBA, c-TAK, PTOV-1, and WEE1). The largest functional classes comprised proteins involved in the regulation of cytoskeletal dynamics, polarity, adhesion, mitogenic signaling, and motility. Accordingly ectopic 14-3-3 expression prevented cellular migration in a wounding assay and enhanced mitogen-activated protein kinase signaling. The functional diversity of the identified proteins indicates that induction of 14-3-3 could allow p53 to affect numerous processes in addition to the previously characterized inhibitory effect on G₂/M progression. The data suggest that the cancer-specific loss of 14-3-3 expression by epigenetic silencing or p53 mutations contributes to cancer formation by multiple routes.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. M. Atkins, L. Thomas, R. T. Youker, M. J. Harriff, F. Pissani, H. You, and G. Thomas HIV-1 Nef Binds PACS-2 to Assemble a Multikinase Cascade That Triggers Major Histocompatibility Complex Class I (MHC-I) Down-regulation: ANALYSIS USING SHORT INTERFERING RNA AND KNOCK-OUT MICE J. Biol. Chem., April 25, 2008; 283(17): 11772 - 11784. [Abstract] [Full Text] [PDF]

				M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178. [Abstract] [Full Text] [PDF]

				D. Bridges and G. B. G. Moorhead 14-3-3 Proteins: A Number of Functions for a Numbered Protein Sci. Signal., August 9, 2005; 2005(296): re10 - re10. [Abstract] [Full Text] [PDF]